US: 1.646.568.9797 (24x5)
UK: 44.330.808.0580 (24x5)
Worldwide: 91.703.051.960 (24x7)
"The ongoing Coronavirus (COVID-19) pandemic is re-shaping everything from global economies to product categories, pricing, and stock availability to the consumer behavior. The final report is updated to address the impact of COVID-19 on the Allergy Immunotherapy market. Trusted Business Insights is tracking mining/oil and gas, transportation, employment services, travel arrangements, and the leisure and hospitality sector closely as they are likely to be the hardest-hit sectors. Utilities, local pharma, diagnostics, consumer goods and durables, agro chem and fertilizers, and telecommunications are the sectors that will be weathering the COVID-19 storm and most likely come out relatively unscathed. Interdependencies of sectors are factored in our research report on the Allergy Immunotherapy market." Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune systems response. The global Allergy Immunotherapy market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. This report focuses on Allergy Immunotherapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Allergy Immunotherapy market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan. At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report. The following manufacturers are covered: ALK-Abello Stallergenes Greer Merck Allergy Therapeutics HAL WOLW Pharma Holister Stier Leti Segment by Regions North America Europe China Japan Segment by Type Subcutaneous Immunotherapy Sublingual Immunotherapy Segment by Application Allergic Rhinitis Allergic Asthma Other
Table of Contents Executive Summary 1 Allergy Immunotherapy Market Overview 1.1 Product Overview and Scope of Allergy Immunotherapy 1.2 Allergy Immunotherapy Segment by Type 1.2.1 Global Allergy Immunotherapy Production Growth Rate Comparison by Type (2014-2025) 1.2.2 Subcutaneous Immunotherapy 1.2.3 Sublingual Immunotherapy 1.3 Allergy Immunotherapy Segment by Application 1.3.1 Allergy Immunotherapy Consumption Comparison by Application (2014-2025) 1.3.2 Allergic Rhinitis 1.3.3 Allergic Asthma 1.3.4 Other 1.4 Global Allergy Immunotherapy Market by Region 1.4.1 Global Allergy Immunotherapy Market Size Region 1.4.2 North America Status and Prospect (2014-2025) 1.4.3 Europe Status and Prospect (2014-2025) 1.4.4 China Status and Prospect (2014-2025) 1.4.5 Japan Status and Prospect (2014-2025) 1.5 Global Allergy Immunotherapy Market Size 1.5.1 Global Allergy Immunotherapy Revenue (2014-2025) 1.5.2 Global Allergy Immunotherapy Production (2014-2025) 2 Global Allergy Immunotherapy Market Competition by Manufacturers 2.1 Global Allergy Immunotherapy Production Market Share by Manufacturers (2014-2019) 2.2 Global Allergy Immunotherapy Revenue Share by Manufacturers (2014-2019) 2.3 Global Allergy Immunotherapy Average Price by Manufacturers (2014-2019) 2.4 Manufacturers Allergy Immunotherapy Production Sites, Area Served, Product Types 2.5 Allergy Immunotherapy Market Competitive Situation and Trends 2.5.1 Allergy Immunotherapy Market Concentration Rate 2.5.2 Allergy Immunotherapy Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Allergy Immunotherapy Production Market Share by Regions 3.1 Global Allergy Immunotherapy Production Market Share by Regions 3.2 Global Allergy Immunotherapy Revenue Market Share by Regions (2014-2019) 3.3 Global Allergy Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019) 3.4 North America Allergy Immunotherapy Production 3.4.1 North America Allergy Immunotherapy Production Growth Rate (2014-2019) 3.4.2 North America Allergy Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019) 3.5 Europe Allergy Immunotherapy Production 3.5.1 ... | read more...